Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N P Restifo

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 11, 2000
Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responsesK Lee, W W Overwijk, M O'Toole, et al.
Journal of the National Cancer Institute|February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancerM G Sanda, N P Restifo, J C Walsh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1994
Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alphaF M Marincola, S Ettinghausen, P A Cohen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitroC J Kim, T Prevette, J Cormier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100Y Zhai, J C Yang, P Spiess, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challengeS Gurunathan, K R Irvine, C Y Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic miceC E Touloukian, W W Leitner, S L Topalian, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
T-cell recognition of human melanoma antigensY Kawakami, M I Nishimura, N P Restifo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expressionJ B Rao, R S Chamberlain, V Bronte, et al.
The Cancer Journal From Scientific American|January 1, 1997
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan AJ N Cormier, M L Salgaller, T Prevette, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 11, 2000
Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responsesK Lee, W W Overwijk, M O'Toole, et al.
Journal of the National Cancer Institute|February 15, 1995
Molecular characterization of defective antigen processing in human prostate cancerM G Sanda, N P Restifo, J C Walsh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1994
Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alphaF M Marincola, S Ettinghausen, P A Cohen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 1, 1997
Dendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitroC J Kim, T Prevette, J Cormier, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100Y Zhai, J C Yang, P Spiess, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challengeS Gurunathan, K R Irvine, C Y Wu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic miceC E Touloukian, W W Leitner, S L Topalian, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1993
T-cell recognition of human melanoma antigensY Kawakami, M I Nishimura, N P Restifo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1996
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expressionJ B Rao, R S Chamberlain, V Bronte, et al.
The Cancer Journal From Scientific American|January 1, 1997
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan AJ N Cormier, M L Salgaller, T Prevette, et al.
Pageof 10